Total Payments
$3,534
2024 Payments
$262.57
Companies
30
Transactions
145
Medicare Patients
795
Medicare Billing
$182,017
Payment Breakdown by Category
Food & Beverage$3,277 (92.8%)
Education$256.19 (7.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,277 | 137 | 92.8% |
| Education | $256.19 | 8 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aurinia Pharma U.S., Inc. | $355.67 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $338.28 | 11 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $257.13 | 10 | $0 (2023) |
| Amgen Inc. | $240.01 | 12 | $0 (2019) |
| OPKO Pharmaceuticals, LLC | $205.86 | 8 | $0 (2024) |
| Vifor Pharma, Inc. | $198.98 | 8 | $0 (2024) |
| Insmed, Inc. | $188.47 | 7 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $155.49 | 7 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $140.71 | 6 | $0 (2021) |
| Shionogi Inc | $140.30 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $262.57 | 10 | OPKO Pharmaceuticals, LLC ($63.06) |
| 2023 | $625.54 | 27 | Aurinia Pharma U.S., Inc. ($134.72) |
| 2022 | $897.72 | 36 | Insmed, Inc. ($188.47) |
| 2021 | $427.19 | 19 | Bayer HealthCare Pharmaceuticals Inc. ($88.75) |
| 2020 | $315.40 | 10 | Otsuka America Pharmaceutical, Inc. ($95.51) |
| 2019 | $407.07 | 15 | Amgen Inc. ($128.55) |
| 2018 | $281.41 | 13 | Amgen Inc. ($75.02) |
| 2017 | $316.77 | 15 | The Medicines Company ($94.96) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $24.33 | General |
| 10/01/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $31.92 | General |
| Category: NEPHROLOGY | ||||||
| 05/01/2024 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $44.77 | General |
| 01/23/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $31.14 | General |
| Category: NEPHROLOGY | ||||||
| 01/11/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/09/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Hyperkalemia | ||||||
| 11/30/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $28.85 | General |
| 11/08/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Cardio-renal | ||||||
| 10/31/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/18/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $8.23 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/04/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.27 | General |
| 10/03/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: NEPHROLOGY | ||||||
| 09/27/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $20.93 | General |
| Category: NEPHROLOGY | ||||||
| 09/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: Cardio-renal | ||||||
| 09/06/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/06/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/30/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: NEPHROLOGY | ||||||
| 08/09/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.49 | General |
| 07/26/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: NEPHROLOGY | ||||||
| 07/12/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/28/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.74 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 34 | $11,686 | $3,693 |
| 2022 | 4 | 75 | 182 | $49,933 | $16,016 |
| 2021 | 6 | 305 | 720 | $176,872 | $59,523 |
| 2020 | 9 | 401 | 1,136 | $311,813 | $102,784 |
Total Patients
795
Total Services
2,072
Medicare Billing
$182,017
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 34 | $11,686 | $3,693 | 31.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 104 | $31,250 | $10,068 | 32.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 43 | $9,008 | $2,758 | 30.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $7,011 | $2,322 | 33.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 23 | $2,664 | $868.20 | 32.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 77 | 210 | $63,672 | $20,997 | 33.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 75 | 197 | $41,617 | $14,225 | 34.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 62 | 189 | $21,232 | $7,194 | 33.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 41 | 47 | $18,935 | $6,408 | 33.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 30 | $17,707 | $5,539 | 31.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 47 | $13,710 | $5,160 | 37.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 95 | 406 | $124,048 | $40,819 | 32.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 79 | 222 | $47,051 | $15,623 | 33.2% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 14 | 48 | $33,874 | $10,569 | 31.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 82 | 267 | $31,098 | $10,128 | 32.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 50 | 58 | $23,773 | $7,766 | 32.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 31 | 36 | $21,486 | $7,214 | 33.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 62 | $14,416 | $4,981 | 34.6% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 11 | 18 | $9,815 | $3,099 | 31.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 19 | $6,252 | $2,586 | 41.4% |
About Dr. Samuel Spitalewitz, MD
Dr. Samuel Spitalewitz, MD is a Nephrology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790760007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Spitalewitz, MD has received a total of $3,534 in payments from pharmaceutical and medical device companies, with $262.57 received in 2024. These payments were reported across 145 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,277).
As a Medicare-enrolled provider, Spitalewitz has provided services to 795 Medicare beneficiaries, totaling 2,072 services with total Medicare billing of $182,017. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Brooklyn, NY
- Active Since 12/08/2005
- Last Updated 04/28/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1790760007
Products in Payments
- LUPKYNIS (Drug) $355.67
- JYNARQUE (Drug) $338.28
- Veltassa (Drug) $318.91
- Kerendia (Drug) $236.81
- Parsabiv (Biological) $220.05
- Arikayce (Drug) $188.47
- RAYALDEE (Drug) $182.42
- ACTHAR (Biological) $171.63
- XARELTO (Drug) $142.32
- Fetroja (Drug) $140.30
- SOLIRIS (Drug) $111.46
- OPSUMIT (Drug) $84.57
- LOKELMA (Drug) $84.18
- NEPHROCHECK TEST (Device) $76.97
- ORBACTIV (Drug) $70.21
- UPTRAVI (Drug) $56.14
- BENLYSTA (Biological) $47.53
- Velphoro (Drug) $40.25
- DIFICID (Drug) $37.16
- TERLIVAZ (Drug) $27.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Brooklyn
Gregg Miller, Md, MD
Nephrology — Payments: $57,485
Nephrology $57,485
Alla Maslova
Nephrology — Payments: $18,516
Nephrology $18,516
Li Yang, Md, MD
Nephrology — Payments: $17,726
Nephrology $17,726
Dr. Louis Carrera, Md, MD
Nephrology — Payments: $17,135
Nephrology $17,135
Dr. Mariana Markell, M.d, M.D
Nephrology — Payments: $15,506
Nephrology $15,506
Dr. Alan Nissenbaum, Md, MD
Nephrology — Payments: $15,228
Nephrology $15,228